Insider Transactions in Q4 2024 at Biogen Inc. (BIIB)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2024
|
Priya Singhal Head of Development |
SELL
Open market or private sale
|
Direct |
110
-1.99%
|
$17,270
$157.21 P/Share
|
|
Dec 06
2024
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-2.58%
|
$26,690
$157.78 P/Share
|
|
Dec 06
2024
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
351
+5.07%
|
-
|
|
Dec 06
2024
|
Priya Singhal Head of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-3.59%
|
$32,342
$157.78 P/Share
|
|
Dec 06
2024
|
Priya Singhal Head of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+6.91%
|
-
|
|
Nov 05
2024
|
Susan H Alexander EVP Chief Legal Officer |
BUY
Bona fide gift
|
Indirect |
20,082
+50.0%
|
-
|
|
Nov 05
2024
|
Susan H Alexander EVP Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
20,082
-38.86%
|
-
|
|
Nov 01
2024
|
Jane Grogan Head of Research |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-29.35%
|
$35,292
$173.79 P/Share
|
|
Nov 01
2024
|
Jane Grogan Head of Research |
BUY
Exercise of conversion of derivative security
|
Direct |
695
+50.0%
|
-
|